News & Updates

Show Multimedia Only
Early vedolizumab treatment uncommon in IBD

Early vedolizumab treatment uncommon in IBD

17 Dec 2021 byRoshini Claire Anthony

In patients with inflammatory bowel disease (IBD), the likelihood of early treatment with vedolizumab is low, a finding that diverts from guideline recommendations, according to a real-world study presented at AIBD 2021.

Early vedolizumab treatment uncommon in IBD

17 Dec 2021
Wrist strap monitors physiological changes in IBD

Wrist strap monitors physiological changes in IBD

17 Dec 2021
Too much processed meat ups mortality risk in IBD patients

Too much processed meat ups mortality risk in IBD patients

15 Dec 2021
Alcohol abstinence lowers HCC risk in patients with cirrhosis

Alcohol abstinence lowers HCC risk in patients with cirrhosis

10 Dec 2021

Abstinence from alcoholic drinks reduces the risk of hepatocellular carcinoma (HCC) in patients with alcohol-related liver cirrhosis, but not in those with a history of decompensated disease, reveals a study.

Alcohol abstinence lowers HCC risk in patients with cirrhosis

10 Dec 2021